Global ratings agency upgrades India’s rating due to structural reforms, resilience and high potential growth


Photo: dbrs.morningstar.com

Photo: dbrs.morningstar.com

Morningstar DBRS, a global ratings agency, has upgraded its rating of India’s long-term and short-term debt on the basis of the country’s structural reform efforts, fiscal consolidation, resilient banking system, and high potential growth rate.

India’s long-term rating was raised to BBB from BBB (low), while short-term rating was raised to R-2 (high) from R-2 (middle). 

“The successful implementation of reforms coupled with infrastructure investment and rapid digitalization have helped drive India’s recovery in the post-pandemic period, with GDP expanding on average by 8.2% from FY22 (April 2021 to March 22) to FY25,” Morningstar DBRS said in its ratings rationale document. “Fiscal consolidation remains on track with improvements in transparency of government accounts and the quality of spending.”

The ratings agency also noted that inflation has returned to the Reserve Bank of India’s comfort band, and that the external sector is strong. 

“While the imposition of U.S. tariffs adds uncertainty to the outlook, India looks comparatively well-positioned, given the low level of goods exports to the U.S. and the domestic-driven nature of the Indian economy,” the agency added.

However, it also raised a few concerns regarding India’s high deficits and debt levels. 

“Despite recent improvements, India’s perennially large fiscal deficits and elevated government debt levels characterise the country’s credit profile,” the agency noted. “On a general government basis, the public debt-to-GDP ratio has moderated since the shock of the pandemic but remains high at 80.2% in FY25.”

Morningstar DBRS added that it could further upgrade India’s credit ratings if it does a combination of things: continues implementing reforms that raise the country’s investment rate and materially reduce the public debt-to-GDP ratio.   



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *